All Episodes

#45 How to perform better disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek

#44 Rethinking medical device safety, part 2 – Omar Aimer

#43 Rethinking medical device safety, part 1 – Omar Aimer

#42 Unpacking the WHO Global Smart Pharmacovigilance Strategy – Shanthi Pal

#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén

#40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén

#39 Putting children first on Patient Safety Day – Angela Caro-Rojas

#38 Patient perspectives in PV: a fireside chat at the ISoP mid-year symposium

#37 Beyond numbers: quality in ADR reporting – Henry Zakumumpa

#36 Pregnancy-related pharmacovigilance – Levente Pápai, Lovisa Sandberg & Sara Vidlin

#35 Veterinary pharmacovigilance, part 2 – James Mount

#34 Veterinary pharmacovigilance, part 1 – James Mount

#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias

#32 Pharmacovigilance in older adults – Giovanni Furlan

#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects

Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance

#30 Preventing and reporting medication errors – Rabat CC & UMC

#29 When medicines change our behaviour – Michele Fusaroli

#28 Catching black swans – François Montastruc

#27 When drugs damage the liver – Rita Baião

#26 What's trending in pharmacovigilance? – Angela Caro-Rojas

#25 A week in the name of medicines safety – part 2

#24 A week in the name of medicines safety – part 1

Uppsala Reports Long Reads – The colour of signals

Uppsala Reports Long Reads – Empowering patients as partners

#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić

#22 Reforming pharmacovigilance education – Michael Reumerman

#21 Unlocking the power of real-world data – Patrick Ryan

#20 The evidence for signals – Daniele Sartori

Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era

#19 Lessons in pandemic pharmacovigilance – Elena Rocca

#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund

#17 Why we need vaccine surveillance systems – Madhava Balakrishnan

#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras

#15 Safety of HIV medications – Henry Zakumumpa

#14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry

#13 How to talk about risks – Alexandra Freeman

Uppsala Reports Long Reads – Safety issues faced by refugee communities

#12 Improving signal detection with vigiGroup – Jim Barrett & Joe Mitchell

#11 Talking about vaccine safety – Anthony Cox & Daniel Salmon

Uppsala Reports Long Reads – The KIDs List

Uppsala Reports Long Reads – Convincing the vaccine hesitant

#10 Tailoring drug therapy to your genes – Qun-Ying Yue

#9 Keeping vaccines safe – Helena Sköld & Annette Rudolph

Uppsala Reports Long Reads – Substandard and falsified COVID-19 vaccines in the Americas

#8 How do we change behaviour around antimicrobial resistance?

Uppsala Reports Long Reads – Into the infodemic

#7 The challenge of rare diseases – Christina Ström Möller

Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research

#6 Intuition in pharmacovigilance – Eugene van Puijenbroek

Uppsala Reports Long Reads – Patient's advocate

Uppsala Reports Long Reads – Vaccination errors risk harm and damage trust

#5 Restoring invisible and abandoned trials – Peter Doshi

#4 Communicating science through film – Matthew Barwick

Uppsala Reports Long Reads – Found in space

Uppsala Reports Long Reads – 10 critical steps for patient safety

#3 Navigating the plant names jungle – Bob Allkin

#2 Why we should listen to patients – Linda Härmark

Uppsala Reports Long Reads – Philosophy of science meets patient safety

Uppsala Reports Long Reads – Ending the pregnant pause

#1 Fighting the fakes – Aline Plançon